GILD

125.59

0.22% -0.28

시간 외 거래: 125.75 0.16 +0.13%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$125.87

열려 있는:

$126.13

하루 거래량:

5.21M

Relative Volume:

0.81

시가총액:

$155.93B

수익:

$29.79B

순이익/손실:

$9.22B

주가수익비율:

17.09

EPS:

7.3494

순현금흐름:

$10.23B

1주 성능:

-2.76%

1개월 성능:

-6.93%

6개월 성능:

+4.31%

1년 성능:

+12.08%

1일 변동 폭

$124.29

$126.50

1주일 범위

$121.39

$130.80

52주 변동 폭

$104.46

$157.29

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1109)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,000

트위터

@GileadSciences

다음 수익 날짜

2026-08-06

최신 SEC 제출 서류

GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, MRK, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	125.59	155.93B	29.79B	9.22B	10.23B	7.3494
LLY Lilly Eli Co	1,133.00	1.01T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	240.87	579.83B	96.36B	21.04B	17.80B	8.6488
ABBV Abbvie Inc	227.73	402.35B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	119.05	294.03B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	153.07	292.07B	54.66B	13.58B	16.05B	7.0171

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-10	개시	Jefferies	Buy
2026-02-20	개시	Barclays	Equal Weight
2026-02-11	재확인	Needham	Buy
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

03:13 AM

Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Yahoo Finance

03:13 AM

07:46 AM

Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

07:46 AM

07:18 AM

Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat

07:18 AM

06:46 AM

Gilead (GILD) Supports Faster South Africa Access to Lenacapavir - Insider Monkey

06:46 AM

06:40 AM

Martingale Asset Management L P Acquires 21,153 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

06:40 AM

Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

06:40 AM

06:30 AM

Titan Investment Solutions Ltd Invests $6.20 Million in Gilead Sciences, Inc. $GILD - MarketBeat

06:30 AM

05:41 AM

Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

05:41 AM

Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

05:41 AM

03:43 AM

Gilead Sciences, Inc. $GILD Shares Purchased by Banco Santander S.A. - MarketBeat

03:43 AM

03:35 AM

Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat

03:35 AM

03:23 AM

4,220,501 Shares in Gilead Sciences, Inc. $GILD Bought by Boston Partners - MarketBeat

03:23 AM

Jun 12, 2026

Gross profit of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

Long term debt to total assets ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh Dividends – BCBA:GILD.CI - TradingView

Jun 12, 2026

GILD Donates Antiviral Therapy to Support Ebola Response in Ugan - GuruFocus

Jun 12, 2026

Gilead donates remdesivir to Uganda for Ebola outbreak response - Investing.com

Jun 12, 2026

Gilead donates remdesivir to Uganda for Ebola outbreak response By Investing.com - Investing.com Canada

Jun 12, 2026

Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief - Yahoo Finance

Jun 12, 2026

UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

FY2026 EPS Forecast for Gilead Sciences Reduced by Analyst - MarketBeat

Jun 12, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - MarketBeat

Jun 12, 2026

Swiss National Bank Has $417.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Te Ahumairangi Investment Management Ltd Sells 8,180 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Meiji Yasuda America Inc Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Gilead Sciences, Inc. $GILD Shares Purchased by Great Lakes Advisors LLC - MarketBeat

Jun 12, 2026

SF: Rememberance Work Is Future Work: Gilead Commits $3M For Hiv/Aids Education And Preservation - SFGATE

Jun 12, 2026

Jun 11, 2026

CAR T-Cell Therapy for Non-Hodgkin’s lymphoma Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Gilead Sciences, Kite Pharma, Novartis, BMS, Allogene Therapeut - Barchart.com

Jun 11, 2026

Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv - GuruFocus

Jun 11, 2026

Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes - Stock Titan

Jun 11, 2026

Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes - Stock Titan

Jun 11, 2026

Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4 - Stock Titan

Jun 11, 2026

Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes - Stock Titan

Jun 11, 2026

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 11, 2026

National AIDS Memorial and the Gilead Foundation Launch Major Investment to Expand HIV/AIDS Education and Community Leadership - Gilead Sciences

Jun 11, 2026

Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now? - Insider Monkey

Jun 11, 2026

Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD) - MarketBeat

Jun 11, 2026

Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled - TradingKey

Jun 11, 2026

Johnson Wealth Management LLC Makes New $2.51 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 11, 2026

Gilead Sciences, Inc. $GILD Shares Bought by Illinois Municipal Retirement Fund - MarketBeat

Jun 11, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by LPL Financial LLC - MarketBeat

Jun 11, 2026

Cerity Partners LLC Buys 19,673 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 11, 2026

Jun 10, 2026

Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development - Insider Monkey

Jun 10, 2026

Gilead Sciences Inc (GILD) Shares Fall 3.2% -- What GF Score of 76 Tells Investors - GuruFocus

Jun 10, 2026

Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jun 10, 2026